首页> 外文期刊>American Journal of Translational Research >Efficacy and prognosis of continuous renal replacement therapy at different times in the treatment of patients with sepsis-induced acute kidney injury
【24h】

Efficacy and prognosis of continuous renal replacement therapy at different times in the treatment of patients with sepsis-induced acute kidney injury

机译:不同时间在不同时期的患者急性肾损伤患者的疗效和预后

获取原文
           

摘要

Objective: To investigate the efficacy and prognosis of CRRT at different times in the treatment of sepsis-induced acute kidney injury (SAKI). Methods: A total of 156 patients with SAKI were grouped into two groups in accordance with a random number table, with 78 patients in each group. Patients in the observation group (OG) were treated with early CRRT, and in the control group (CG), patients were treated with delayed CRRT. According to whether the patients died, there were 51 cases in the death group and 105 in the survival group. Renal function and inflammatory factors were compared before and after treatment; univariate and multilateral comparison were conducted to analyze the survival status of the patients. Results: After treatment, the blood urea nitrogen (BUN) and serum creatinine (Scr) in both groups fell below those prior to treatment, while the estimated glomerular filtration rate (eGFR) was elevated (P0.01); the decrease of BUN and Scr in the OG was greater than that of the other group, while increase eGFR was more than that the other group (P0.01). After treatment, C-reactive protein (CRP), tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in both groups decreased compared to that prior to treatment (P0.001); the decrease of the three factors in the OG was greater than that in the CG (P0.05). The 60-day survival rate of patients in the OG was 76.92%, which was higher that of 57.69% in the CG (P0.05). The age, acute physiology and chronic health enquiry (APACHE-II) score and proportion of chronic obstructive pulmonary disease (COPD) in the death group was elevated compared to those in the survival group, while the number of patients with early CRRT and eGFR level before treatment were lower than those in the survival group (P0.05). Age was an independent risk factor for the prognosis of SAKI, and early CRRT was a protective factor for the prognosis (P0.05). Conclusion: Early CRRT for SAKI can improve the renal function and inflammatory state effectively, and reduce the mortality of patients. Age is an independent risk factor affecting the prognosis of patients with SAKI, and early CRRT is a protective factor for the prognosis.
机译:目的:探讨CRRT在不同时间治疗脓毒症诱导的急性肾损伤(SAKI)的疗效和预后。方法:根据随机数表将156例SAKI患者分为两组,每组78例患者。观察组(OG)中的患者用早期CRRT治疗,并在对照组(CG)中,用延迟CRRT治疗患者。根据患者是否死亡,死亡组中有51例,存活组105例。在治疗之前和之后比较肾功能和炎症因子;进行单变量和多边比较,以分析患者的存活状态。结果:治疗后,两组中的血液尿素氮(BUN)和血清肌酐(SCR)下降到治疗之前,而估计的肾小球过滤速率(EGFR)升高(P <0.01); OG中的BUN和SCR的减少大于另一组的细胞,而增加EGFR大于另一组(P <0.01)。在处理之前,在治疗后,C反应蛋白(CRP),肿瘤坏死因子-α(TNF-α)和白细胞介素-6(IL-6)与治疗相比降低(P <0.001); OG中的三个因子的减少大于CG中的两个因子(P <0.05)。 OG患者的60天存活率为76.92%,CG中的57.69%较高(P <0.05)。与存活组中的死亡组的年龄,急性生理学和慢性健康调查(Apache-II)评分和慢性阻塞性肺病(COPD)的比例升高,而早期CRRT和EGFR水平的患者数量在治疗之前低于存活基团(P <0.05)。年龄是SAKI预后的独立危险因素,早期CRRT是预后的保护因素(P <0.05)。结论:SAKI的早期CRRT可有效提高肾功能和炎症状态,降低患者的死亡率。年龄是影响SAKI患者预后的独立危险因素,早期CRRT是预后的保护因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号